Home
ANEXT Brand
ANEXT Brand
Brand Culture
Brand Partners
Super Ingredients
Exosome Origin
Application Area
Technology Platform
ANEXT Super Delivery
®
ANEXT Smart Ex
®
R&D Pipeline
Property Rights (Law)
R&D and Production Support
Research Literature
Industry Impact
Exosome Research Direction
Global Exosome Company
Exosome Related Informations
About Us
About ANEXT
ANEXT Teams
Development History
Global Bases
ANEXT News
Contact Us
Join Us
Search
Chinese
ANEXT Brand
ANEXT Brand
Brand Culture
Brand Partners
Super Ingredients
Exosome Origin
Application Area
Technology Platform
ANEXT Super Delivery
®
ANEXT Smart Ex
®
R&D Pipeline
Property Rights (Law)
R&D and Production Support
Research Literature
Industry Impact
Exosome Research Direction
Global Exosome Company
Exosome Related Informations
About Us
About ANEXT
ANEXT News
Contact Us
Join Us
CN
EN
HOME
ANEXT Brand
ANEXT Brand
Brand Culture
Brand Partners
Super Ingredients
Exosome Origin
Application Area
Technology Platform
ANEXT Super Delivery
®
ANEXT Smart Ex
®
R&D Pipeline
Property Rights (Law)
R&D and Production Support
Research Literature
Industry Impact
Exosome Research Direction
Global Exosome Company
Exosome Related Informations
About Us
ANEXT Teams
Development History
Global Bases
ANEXT News
Contact Us
Join Us
work as one
Moving the world forward
ANEXT News
Witness our
development
together.
HOME
>
About Us
>
ANEXT News
>
安龄生物荣登“2024中国生物医药领跑者TOP100”榜单
安龄生物荣登“2024中国生物医药领跑者TOP100”榜单
Last:
会议回顾:安龄生物出席第十一届细胞生物产业大会分享外泌体临床进展及应用趋势
Next:
【心有安龄 沐光前行】美好向新,2024安龄迎新季
Back
News Recommendations
2024-01-05
全球唯一!ANEXT安龄生物间充质干细胞外泌体成功获得FDA DMF备案
2024-01-05
“先行探索·美丽加速”安龄生物国际化妆品大会报告亮出生物技术抗衰老与逆转衰老医工结合新思路
Global
-Exosome Related Informations
2025-08-11
哮喘治疗革命性突破:干细胞外泌体雾化吸入开启生物疗法新时代
2025-08-11
全球首次证实!干细胞外泌体联合疗法实现慢性肝衰竭动物模型功能性逆转
National
-Exosome Related Informations
2025-06-13
鼻腔直通神经元:外泌体雾化重塑阿尔茨海默病治疗疆界
2025-06-13
千亿神经战场,全球外泌体疗法临床攻坚战